• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Dutasteride Teva
    / Teva Israel LTD, Israel


    Active Ingredient
    Dutasteride 0.5 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Soft Capsules

    30 X 0.5 mg

    not in the basket chart 20083

    Dosage

    The usual dose is generally one capsule (0.5 mg) taken once a day.


    Indications

    Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH).
    Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.


    Contra-Indications

    *Hypersensitivity to other 5-alpha-reductase inhibitors or to any of drug’s excipients.
    *Patients with severe hepatic disease.
    *Female patients, children or adolescents.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.


    Important notes

    Keep in the original package to protect from light.


    Manufacturer
    Teva Israel LTD, Israel
    CLOSE